Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Suzhou Fourth Pharmaceutical Co., Ltd., formerly known as Suzhou No. 4 Pharmaceutical Factory, is a prominent Chinese pharmaceutical manufacturer specializing in the production of anti-infective agents. Established in 1952 and based in Suzhou, the company has grown into a leading producer of cephalosporins, penicillins, and other essential antibiotics. It operates large-scale, GMP-certified manufacturing facilities that produce both Active Pharmaceutical Ingredients (APIs) and finished dosage forms, including injections, capsules, and tablets. As a key subsidiary of the Suzhou Pharmaceutical Group, the company serves a global market, exporting its products to over 30 countries and regions. Suzhou Fourth Pharmaceutical is recognized for its long-standing history in the chemical-pharmaceutical industry and its commitment to providing high-quality, affordable medicines for infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Suzhou Pharmaceutical Factory.